COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    READISCA
Previous Study | Return to List | Next Study

Clinical Trial Readiness for SCA1 and SCA3 (READISCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03487367
Recruitment Status : Recruiting
First Posted : April 4, 2018
Last Update Posted : April 27, 2020
University of Michigan
University of Minnesota
University of Utah
University of California, Los Angeles
University of Chicago
University of South Florida
Harvard University
Johns Hopkins University
University of Florida
Columbia University
Emory University
University of California, San Francisco
University of Alabama at Birmingham
University of Colorado, Denver
University of Rochester
Stanford University
Northwestern University
German Center for Neurodegenerative Diseases (DZNE)
Institut de Recherche sur la Moelle épinière et l'Encéphale
University of Pennsylvania
Ohio State University
University of Iowa
Information provided by (Responsible Party):
Tetsuo Ashizawa, MD, The Methodist Hospital System

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : December 31, 2022